Sample institutional deep dives — each stock run through the AlphaLens research frameworks with live prices, SEC filings, and current news. Newest first.
This index URL stays put. Individual reports keep their dated URLs (e.g. /analysis/nvda-2026/) so earlier analysis stays citable.
Q1 FY2027 earnings day, stock at a 52-week low: the complete, unedited run of all 15 AlphaLens frameworks, with reviewer notes on the errors we found.
Read the full run →FY2026 diluted EPS $20.76, a stock near 44.5x trailing earnings, and a one-time tariff refund tucked inside this quarter's growth rate. Full Company Breakdown, Fair Value Stress Test, and Revenue Quality Decomposer.
Read the analysis →Cloud revenue up 62%, record backlog, and a stock down 57% from its high. Debt Maturity Wall and Liquidity, Leverage & Commitments on what the capex is actually costing.
Read the analysis →Spun off from FedEx carrying new debt, then down 44% from its trading-life high. Fair Value, Earnings Quality, Macro Sensitivity, Competitor Moat, and Management Quality on the numbers as filed.
Read the analysis →Record Q2 FY2027 revenue, a genuine earnings beat, and the stock sold off anyway. Fair Value Stress Test and Earnings Quality Analyzer on what the selloff actually says.
Read the analysis →HBM supercycle thesis ahead of the September 22 earnings print — fair value stress test, management scorecard, macro sensitivity, and the single number that matters.
Read the analysis →The NorrisAI Accrual Screen flagged VVV for cash/earnings divergence. 13 frameworks applied, and what the divergence actually turned out to be.
Read the case study →AWS margin expansion, advertising growth, the AI capex bet, and a fair value stress test. Base case $420, bull $510, bear $240.
Read the analysis →Q3 FY2026: EPS beat, guidance miss, stock down after hours. DCF fair value, Google TAC risk, and a cyclical compounder masquerading as defensive.
Read the analysis →CUDA moat depth, the Blackwell ramp, Jensen Huang's management grade, and why hyperscaler capex is the only number that matters.
Read the analysis →The 177% single-day surge on melanoma vaccine trial data — the bull case, the bear case, and what the valuation math actually looks like.
Read the analysis →Ninth straight earnings beat, 149% US commercial growth, and the valuation tension at 40x forward revenue — across 15 frameworks.
Read the analysis →Up 6,000%+ since the 2025 Western Digital spinoff — the Q4 FY26 beat, the Investor Day reaction, and the real bear case.
Read the analysis →Q2 2026: EPS miss, 8% selloff, FCF compression, and AI capex under scrutiny — Full Company Breakdown, Bull vs Bear, Fair Value Stress Test, Long-Term Thesis, Catalyst Calendar.
Read the analysis →The largest IPO in history at a $1.77T valuation: fair value stress test, the Starlink thesis, and why Starship optionality is secondary.
Read the analysis →Q2 2026 earnings: record $28.2B revenue, a 57% operating income drop, and a sharp EPS miss — run through the research frameworks.
Read the analysis →